Halo Pharmaceutical

A Whippany, NJ-based provider of outsourced development and manufacturing services to the global pharma industry.

Launch date

2006

Employees

Market cap

Enterprise valuation

€386m (Public information from Jul 2018)

United States (HQ)

Date	Investors	Amount	Round
Jan 2015	SK Capital Partners	N/A	Growth Equity VC
Jul 2018	Cambrex Corporation	$425m Valuation: $425m	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Halo Pharmaceutical